Evidence map›Paper›PMID 35769339›Full record

ArticlePatient preference and adherence2022

Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.

Walid Al-Qerem, Anan Jarab, Alaa Hammad, Alaa Hussein Alsajri, Shadan Waleed Al-Hishma, Jonathan Ling, Asal Saad Alabdullah, Ali Salama, Rami Mosleh

Open access · goldAbstract read
In one paragraph

Article in Patient preference and adherence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 5 countries.

Walid Al-QeremDepartment of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.ORCID 0000-0001-9831-7572
Anan JarabDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Alaa HammadDepartment of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
Alaa Hussein AlsajriSpecialized Bone Marrow Transplant Center, Baghdad, Iraq.ORCID 0000-0003-3567-3208
Shadan Waleed Al-HishmaSpecialized Bone Marrow Transplant Center, Baghdad, Iraq.ORCID 0000-0002-7906-3818
Jonathan LingDepartment of Pharmacy, Faculty of Science and Wellbeing University of Sunderland, Sunderland, UK.ORCID 0000-0003-2932-4474
Asal Saad AlabdullahFaculty of Pharmacy, University of Jordan, Amman, Jordan.
Ali SalamaDepartment of Pharmacy, Faculty of Pharmacy, Middle East University, Amman, Jordan.
Rami MoslehDepartment of Pharmacy, Faculty of Medicine & Health Sciences, An-Najah National University, Nablus, Palestine.ORCID 0000-0001-6810-8390
Al-Zaytoonah University of Jordan · JOAn-Najah National University · PSBaghdad Medical City · IQJordan University of Science and Technology · JOMiddle East University · JOUniversiti Sains Malaysia · MYUniversity of Jordan · JOUniversity of Sunderland · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: COVID-19 vaccines are critical for containing the pandemic and preventing serious SARS-CoV-2 infections. In addition to the two main doses, a booster dose has been utilized to improve immunity. The aim of current study is to evaluate Iraqi adult population knowledge, attitudes, and practices towards COVID-19 booster dose. Subjects and Methods: This online cross-sectional survey of adult Iraqis (n = 754) assessed the attitudes of people who have had both immunizations regarding a potential COVID-19 vaccine booster dosage and to identify potential factors that might impact these attitudes. Factors evaluated in the current study included previously received vaccine type in the first two doses, socioeconomic characteristics, health status, knowledge about COVID-19 and its vaccines and adherence to protective practices. Results: Overall, 61.1% of participants expressed willingness to receive a COVID-19 booster dose, with a high median score of knowledge and practice toward COVID-19. Participants who did not perceive COVID-19 to be serious, Conclusion: There is high hesitancy towards COVID-19 booster dose acceptance among the Iraqi population. The study identified several factors associated with vaccine hesitancy including low socioeconomic status and low knowledge about COVID-19 and its vaccines.

Indexed as

booster doseCOVID-19 vaccineIraqSARS-CoV-2vaccine hesitancy

Identifiers

PMID35769339
PMCPMC9236163
OpenAlexW4283387587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.